Skip to content
value.today

Immutep Ltd: valuation

What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.

The market value here is from Aug 1, 2026, more than 60 days ago: no market-data feed is connected for this exchange yet, so read the comparisons with today's price with that in mind.

Cash-flow value

Free cash flow over the last three years averaged below zero, so a cash-flow value cannot be worked out.

Price to salesPrice to sales of Biotechnology: $15 M to $68 M, median $33 MPrice to bookPrice to book of Biotechnology: $287 M to $1.2 B, median $421 M$0 M$326 M$653 M$979 M$1.3 BMarket value $56 M

Your own DCF model

A full discounted-cash-flow model of Immutep Ltd, started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.

Open the DCF model

Against the industry Biotechnology

Multiples of its companies with a market value at most 60 days old, times Immutep Ltd's own figures of FY2025.

Values from the peers' multiples
MultiplePeers (25th / median / 75th)Immutep LtdApplied toValue (25th to 75th)Companies
Price to sales2.2× / 5.0× / 10.2×8.4×revenue $7 M$15 M to $68 M84
Price to book3.1× / 4.5× / 12.9×0.6×book equity $94 M$287 M to $1.2 B69

Against its own history

Immutep Ltd's multiples at each month end with a market cap on file, Jan 2020 to Oct 2026, each against its own median.

Price to sales

744.6×

Now above its median of 412.6×, in the top quarter of its range; range 8.4× to 814.3× over 19 months.

0×204×407×611×814×2020202120222023202420252026Price to sales 745×Median 413×

Price to book

53.1×

Now above its median of 19.9×, in the top quarter of its range; range 0.6× to 74.0× over 20 months.

0×19×37×56×74×2020202120222023202420252026Price to book 53×Median 20×

As of Oct 15, 2026

The statements it starts from

USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.

Figures from the annual statements
Fiscal yearRevenueNet incomeCash from operationsCapital spendingFree cash flowNet debtSource
FY2025to Jun 30, 2025$7 M$-40 M$-40 M$0 M$-40 M—SEC annual report (10-K, 20-F)
FY2024to Jun 30, 2024$5 M$-28 M$-23 M$0 M$-23 M—SEC annual report (10-K, 20-F)
FY2023to Jun 30, 2023$4 M$-27 M$-24 M$0 M$-24 M—SEC annual report (10-K, 20-F)
FY2022to Jun 30, 2022$5 M$-23 M$-22 M$0 M$-22 M—SEC annual report (10-K, 20-F)
FY2021to Jun 30, 2021$3 M$-22 M$-13 M$0 M$-13 M—SEC annual report (10-K, 20-F)
FY2020to Jun 30, 2020$11 M$-9 M$-7 M$0 M$-7 M—SEC annual report (10-K, 20-F)